The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Cardiovascular diseases: protective effects of melatonin
Open accessAbstract
This brief review considers some of the cardiac diseases and conditions where free radicals and related reactants are believed to be causative. The report also describes the beneficial actions of melatonin against oxidative cardiovascular disorders. Based on the data available, melatonin seems to have cardioprotective properties via its direct free radical scavenger and its indirect antioxidant activity. Melatonin efficiently interacts with various reactive oxygen and reactive nitrogen species (receptor independent actions) and it also upregulates antioxidant enzymes and downregulates pro‐oxidant enzymes (receptor‐dependent actions). Moreover, melatonin enters all cells and subcellular compartments and crosses morphophysiologic barriers. These findings have implications for the protective effects of melatonin against cardiac diseases induced by oxidative stress. Melatonin attenuates molecular and cellular damages resulting from cardiac ischemia/reperfusion in which destructive free radicals are involved. Anti‐inflammatory and antioxidative properties of melatonin are also involved in the protection against a chronic vascular disease, atherosclerosis. The administration of melatonin, as a result of its antioxidant features, has been reported to reduce hypertension and cardiotoxicity induced by clinically used drugs. The results described herein help to clarify the beneficial effects of melatonin against these conditions and define the potential clinical applicability of melatonin in cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“The enzyme very efficiently promotes the conversion of H2O2 to H2O and O2 [46]:”
BackgroundRegulation of antioxidant enzymes: a significant role for melatonin
Rodriguez, C., Mayo, J. C., Sainz, R. M., Antolín, I., Herrera, F., Martín, V., & Reiter, R. J. (2004) · Journal of Pineal Research · doi:10.1046/j.1600-079x.2003.00092.x · Cited by 1,987
Self-citationTan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601
Self-citationTan, D.-X., Reiter, R., Manchester, L., Yan, M.-T., El-Sawi, M., Sainz, R., Mayo, J., Kohen, R., Allegra, M., & Hardelan, R. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023394443 · Cited by 1,065
Self-citationRole of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Oxidant and antioxidant balance in the airways and airway diseases
Rahman, I., Biswas, S. K., & Kode, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.087 · Cited by 727
The chemistry of melatonin's interaction with reactive species
Allegra, M., Reiter, R. J., Tan, D. ‐., Gentile, C., Tesoriere, L., & Livrea, M. A. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.02112.x · Cited by 718
Self-citationHardeland, R. (2005) · Endocrine · doi:10.1385/endo:27:2:119 · Cited by 671
A Review of the Multiple Actions of Melatonin on the Immune System
Carrillo-Vico, A., Guerrero, J. M., Lardone, P. J., & Reiter, R. J. (2005) · Endocrine · doi:10.1385/endo:27:2:189 · Cited by 666
Self-citationMelatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
Reiter, R. J., Tan, D.-X., Mayo, J. C., Sainz, R. M., Leon, J., & Czarnocki, Z. (2003) · Acta Biochimica Polonica · doi:10.18388/abp.2003_3637 · Cited by 621
Self-citationDeleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.
Kloner, R. A., Przyklenk, K., & Whittaker, P. (1989) · Circulation · doi:10.1161/01.cir.80.5.1115 · Cited by 504
A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes
Tomás‐Zapico, C., & Coto‐Montes, A. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00248.x · Cited by 503
Tan, D.-X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Limson, J., Weintraub, S. T., & Qi, W. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00435-4 · Cited by 474
Self-citationDaily nighttime melatonin reduces blood pressure in male patients with essential hypertension
Scheer, F. A. J. L., Van Montfrans, G. A., van Someren, E. J. W., Mairuhu, G., & Buijs, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000113293.15186.3b · Cited by 451
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
Moens, A. L., Claeys, M. J., Timmermans, J. P., & Vrints, C. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.013 · Cited by 448
Melatonin: reducing the toxicity and increasing the efficacy of drugs
Reiter, R. J., Tan, D.-X., Sainz, R. M., Mayo, J. C., & Lopez-Burillo, S. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760345374 · Cited by 417
Self-citationHardeland, R., Pandi-Perumal, S. R., & Cardinali, D. P. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.020 · Cited by 390
Cellular mechanisms of ischemia-reperfusion injury
Piper, H. M., Meuter, K., & Schäfer, C. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04686-6 · Cited by 353
Basic Mechanisms of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Injury
Papaharalambus, C. A., & Griendling, K. K. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.11.005 · Cited by 351
POEGGELER, B., SAARELA, S., REITER, R. J., TAN, D., CHEN, L., MANCHESTER, L. C., & BARLOW‐WALDEN, L. R. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21831.x · Cited by 351
Self-citationMayo, J. C., Sainz, R. M., Tan, D.-X., Hardeland, R., Leon, J., Rodriguez, C., & Reiter, R. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.002 · Cited by 332
Self-citationMelatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart
REITER, R., & TAN, D. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00827-1 · Cited by 316
Self-citationKarbownik, M., & Reiter, R. J. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22502.x · Cited by 313
Self-citationRole of free radicals and antioxidants in health and disease.
Flora, S. J. S. (2007) · PubMed · Cited by 300
Melatonin as antioxidant, geroprotector and anticarcinogen
Anisimov, V. N., Popovich, I. G., Zabezhinski, M. A., Anisimov, S. V., Vesnushkin, G. M., & Vinogradova, I. A. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.012 · Cited by 264
Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease
Kruidenier, L., Kuiper, I., van Duijn, W., Mieremet‐Ooms, M. A., van Hogezand, R. A., Lamers, C. B., & Verspaget, H. W. (2003) · The Journal of Pathology · doi:10.1002/path.1408 · Cited by 224
Manda, K., Ueno, M., & Anzai, K. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00432.x · Cited by 222
Reiter, R. J., Tan, D.-X., & Burkhardt, S. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00384-0 · Cited by 213
Self-citationMelatonin as a potential antihypertensive treatment
Simko, F., & Paulis, L. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00436.x · Cited by 207
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
Reiter, R. J., Tan, D. X., Gitto, E., Sainz, R. M., Mayo, J. C., León, J., Manchester, L. C., Vijayalaxmi, V., Kılıç, E., & Kılıç, Ü. (2004) · PubMed · Cited by 189
Self-citationMelatonin and its precursors scavenge nitric oxide
Noda, Y., Mori, A., Liburdy, R., & Packer, L. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00611.x · Cited by 185
Ischemia/reperfusion‐induced arrhythmias in the isolated rat heart: Prevention by melatonin
Tan, D., Manchester, L. C., Reiter, R. J., Qi, W., Kim, S. J., & El‐Sokkary, G. H. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00558.x · Cited by 183
Self-citationRosen, J., Than, N. N., Koch, D., Poeggeler, B., Laatsch, H., & Hardeland, R. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00379.x · Cited by 178
Antioxidant properties of melatonin: a pulse radiolysis study
Mahal, H. S., Sharma, H. S., & Mukherjee, T. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00226-3 · Cited by 167
Nitrosation of melatonin by nitric oxide and peroxynitrite
Blanchard, B., Pompon, D., & Ducrocq, C. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2000.290308.x · Cited by 166
León, J., Escames, G., Rodríguez, M. I., López, L. C., Tapias, V., Entrena, A., Camacho, E., Carriòn, M. D., Gallo, M. Á., Espinosa, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04029.x · Cited by 162
Self-citationOxidative stress and vascular damage in hypertension
Berry, C., Brosnan, M. J., Fennell, J., Hamilton, C. A., & Dominiczak, A. F. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200103000-00014 · Cited by 161
Nava, M., Quiroz, Y., Vaziri, N. D., & Rodríguez‐Iturbe, B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00264.2002 · Cited by 154
Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats
Vural, H., Sabuncu, T., Arslan, S. O., & Aksoy, N. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310301.x · Cited by 153
Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?
Wilund, K. R. (2007) · Clinical Science · doi:10.1042/cs20060368 · Cited by 138
Rezzani, R. (2006) · PubMed · doi:10.14670/hh-21.301 · Cited by 133
Self-citationŞahna, E., Parlakpınar, H., Türköz, Y., & Acet, A. (2005) · Physiological Research · doi:10.33549/physiolres.930664 · Cited by 131
Potential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation
Cuzzocrea, S., Thiemermann, C., & Salvemini, D. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365396 · Cited by 129
Petrosillo, G., Venosa, N. D., Pistolese, M., Casanova, G., Tiravanti, E., Colantuono, G., Federici, A., Paradies, G., & Ruggiero, F. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4692com · Cited by 129
Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo
Lee, Y., Chen, H. I., Hsiao, G., Sheu, J., Wang, J., & Yen, M. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.01869.x · Cited by 129
Kai, H., Mori, T., Tokuda, K., Takayama, N., Tahara, N., Takemiya, K., Kudo, H., Sugi, Y., Fukui, D., Yasukawa, H., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.711 · Cited by 122
Digging deep – structure–function relationships in the melatonin receptor family
Barrett, P., Conway, S., & Morgan, P. J. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00090.x · Cited by 120
Escames, G., Acuña-Castroviejo, D., López, L. C., Tan, D.-X., Maldonado, M. D., Sánchez-Hidalgo, M., León, J., & Reiter, R. J. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.9.0001 · Cited by 118
Self-citationMelatonin and the cardiovascular system.
Sewerynek, E. (2002) · PubMed · Cited by 114
Aydoğan, S., Yerer, M. B., & Göktaş, A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345555 · Cited by 110
Kaneko, S., Okumura, K., Numaguchi, Y., et al. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00607-x · Cited by 103
Is hypertension an inflammatory disease?
Li, J., Fang, C., & Hui, R.-T. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.017 · Cited by 98
Onuki, J., de Almeida, E. A., de Medeiros, M. H. G., & Mascio, P. D. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00180.x · Cited by 92
Pecháňová, O., Zicha, J., Paulis, L., Zenebe, W. J., Dobešová, Z., Vranková, S., Jendeková, L., Sládková, M., Dovinová, I., Šimko, F., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.035 · Cited by 91
Álvarez, Y., Pérez-Girón, J. V., Hernanz, R., Briones, A. M., García‐Redondo, A. B., Beltrán, A. E., Alonso, M. J., & Salaíces, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115287 · Cited by 88
Zavodnik, I. B., Domanski, A. V., Lapshina, E. A., Bryszewska, M. J., & Reiter, R. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.01.030 · Cited by 87
Self-citationShort‐ and long‐term effects of melatonin on myocardial post‐ischemic recovery
Lochner, A., Genade, S., Davids, A., Ytrehus, K., & Moolman, J. A. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00280.x · Cited by 86
Dobšák, P. (2003) · Pathophysiology · doi:10.1016/s0928-4680(02)00080-9 · Cited by 82
Şahna, E., Ölmez, E., & Acet, A. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.1o853.x · Cited by 81
Turjanski, A. G., Leonik, F. M., Estrin, D. A., Rosenstein, R. E., & Doctorovich, F. A. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002006u · Cited by 80
Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan, V. (2002) · PubMed · Cited by 77
Masuyama, H., Tsuruda, T., Kato, J., Imamura, T., Asada, Y., Stasch, J., Kitamura, K., & Eto, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000241087.12492.47 · Cited by 76
Girouard, H., Chulak, C., Lejossec, M., Lamontagne, D., & de Champlain, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200301000-00028 · Cited by 75
Dziegiel, P., Murawska‐Ciałowicz, E., Jethon, Z., Januszewska, L., Podhorska‐Okołów, M., Surowiak, P., Zawadzki, M., Rabczyński, J., & Zabel, M. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00079.x · Cited by 73
Domínguez‐Rodríguez, A., Abreu-González, P., García‐González, M. J., Ferrer-Hita, J. J., Vargas, M., & Reiter, R. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.003 · Cited by 69
Self-citationSüzen, S., Bozkaya, P., Çoban, T., & Nebioğlu, D. (2006) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360500381210 · Cited by 69
Melatonin Protects Against Ischaemic-reperfusion Myocardial Damage
Salie, R., Harper, I. S., Cillie, C., Genade, S., Huisamen, B., Moolman, J. A., & Lochner, A. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1306 · Cited by 67
Şahna, E., Parlakpınar, H., Özer, M. K., Öztürk, F., Özuğurlu, F., & Acet, A. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00084.x · Cited by 65
Girouard, H., Denault, C., Chulak, C., & deChamplain, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.009 · Cited by 65
The γ-subunit of ENaC is more important for channel surface expression than the β-subunit
Konstas, A.-A., & Korbmacher, C. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2002 · Cited by 57
Cao, Z., Zhu, H., Zhang, L., Zhao, X., Zweier, J. L., & Li, Y. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100809 · Cited by 56 · cited 1×
“In this context, administration of some exogenous antioxidative compounds has been shown to exert protection against oxidative cardiovascular disorders [21].”
BackgroundInhibition of LDL oxidation by melatonin requires supraphysiologic concentrations
Duell, P. B., Wheaton, D. L., Shultz, A., & Nguyen, H. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.9.1931 · Cited by 48
Effect of melatonin and metabolites on copper‐mediated oxidation of low density lipoprotein
Seeger, H., Mueck, A. O., & Lippert, T. H. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00648.x · Cited by 45
Melatonin Protects LDL from Oxidation but Does Not Prevent the Apolipoprotein Derivatization
Pieri, C., Marra, M., Gáspár, R., & Damjanovich, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0731 · Cited by 45
Rezzani, R., Rodella, L. F., Dessy, C., Daneau, G., Bianchi, R., & Féron, O. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00898-6 · Cited by 44
Self-citationEffect of melatonin on the cardiotoxicity of doxorubicin.
Ballı, E., Mete, U., Tuli, A., Tap, Ö., & Kaya, M. (2004) · PubMed · doi:10.14670/hh-19.1101 · Cited by 43
Melatonin inhibits oxidative modification of human low‐density lipoprotein
Kelly, M. R., & Loo, G. T. (1997) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1997.tb00323.x · Cited by 43
Wakatsuki, A., Okatani, Y., Ikenoue, N., Izumiya, C., & Kaneda, C. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.280302.x · Cited by 42
Carampin, P., Rosan, S., Dalzoppo, D., Zagotto, G., & Zatta, P. F. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00020.x · Cited by 41
Baljinnyam, E., Hasebe, N., Morihira, M., Sumitomo, K., Matsusaka, T., Fujino, T., Fukuzawa, J., Ushikubi, F., & Kikuchi, K. (2006) · Hypertension Research · doi:10.1291/hypres.29.905 · Cited by 38
Review: From Hypertension to Heart Failure — Are There Better Primary Prevention Strategies?
Meredith, P., & Östergren, J. (2006) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2006.012 · Cited by 36
Eşrefoğlu, M., Gül, M., Parlakpınar, H., & Acet, A. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00331.x · Cited by 29
Török, J., Koprdová, R., Cebová, M., et al. (2006) · Physiological Research · doi:10.33549/physiolres.930000.55.s1.65 · Cited by 27
Rodella, L. F., Bonomini, F., Rezzani, R., Tengattini, S., Hayek, T., Aviram, M., Keidar, S., Coleman, R., & Bianchi, R. (2006) · Acta Histochemica · doi:10.1016/j.acthis.2006.08.002 · Cited by 15
Self-citationTailleux, A., Gozzo, A., Torpier, G., Martin‐Nizard, F., Bonnefont‐Rousselot, D., Lemdani, M., Furman, C., Foricher, R., Chevé, G., Yous, S., et al. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000175232.11079.7e · Cited by 15
Turjanski, A. G., Chaia, Z. D., Doctorovich, F. A., Estrin, D. A., Rosenstein, R. E., & Piro, O. E. (2000) · Acta Crystallographica Section C Crystal Structure Communications · doi:10.1107/s010827010000456x · Cited by 14
Bonnefont‐Rousselot, D., Guilloz, V., Lepage, S., Bizard, C., Duriez, P., Lesieur, D., Delattre, J., Jore, D., & Gardès-Albert, M. (2003) · Redox Report · doi:10.1179/135100003125001413 · Cited by 10
Cited by
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
Galano, A., Tan, D. X., & Reiter, R. J. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12010 · Cited by 795
Self-citationMelatonin membrane receptors in peripheral tissues: Distribution and functions
Slominski, R. M., Reiter, R. J., Schlabritz-Loutsevitch, N., Ostrom, R. S., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.004 · Cited by 675
Self-citationLi, H., Cai, J., Chen, R., Zhao, Z., Ying, Z., Wang, L., Chen, J., Hao, K., Kinney, P. L., Chen, H., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026796 · Cited by 521
Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
Reiter, R. J., Paredes, S. D., Manchester, L. C., & Tan, D.-X. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903044914 · Cited by 478
Self-citation
Metadata
- Authors
- Tengattini, S., Reiter, R. J., Tan, D., Terron, M. P., Rodella, L. F., & Rezzani, R.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2007-10-31
- Volume
- 44
- Issue
- 1
- Pages
- 16-25
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2019384027
- Cited by
- 337
- References
- 87
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.